These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13564395)

  • 21. [Effect of some drugs affecting the central nervous system on thyroxinaccelerated metamorphosis of Rana temporaria].
    TATERKA-SEILER W
    Arzneimittelforschung; 1958 May; 8(5):304-5. PubMed ID: 13535386
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paper chromatographic identification of pipradrol, azacyclonol & other drugs effecting the central nervous system].
    DUMONT C; BOISSIER JR
    Ann Pharm Fr; 1958 Apr; 16(4):256-60. PubMed ID: 13583715
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs.
    TEDESCHI DH; TEDESCHI RE; FELLOWS EJ
    J Pharmacol Exp Ther; 1959 Jul; 126(3):223-32. PubMed ID: 13673372
    [No Abstract]   [Full Text] [Related]  

  • 24. [New drugs with central nervous action; clinical experience and considerations].
    OSTERMAN E; LASSENIUS B; NORDMAN LO
    Nord Med; 1957 May; 57(20):699-703. PubMed ID: 13441129
    [No Abstract]   [Full Text] [Related]  

  • 25. Central nervous system and other effects.
    Young A
    Adv Pharmacol; 2005; 52():281-8. PubMed ID: 16492554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evaluation of Pachyrrhizus erosus (L) seeds for central nervous system depressant activity.
    Abid M; Hrishikeshavan HJ; Asad M
    Indian J Physiol Pharmacol; 2006; 50(2):143-51. PubMed ID: 17051733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS-MODE approach.
    Cabrera Pérez MA; Sanz MB
    Bioorg Med Chem; 2004 Nov; 12(22):5833-43. PubMed ID: 15498659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulus gated cocaine sensitization: interoceptive drug cue control of cocaine locomotor sensitization.
    Carey RJ; DePalma G; Damianopoulos E; Shanahan A
    Pharmacol Biochem Behav; 2005 Oct; 82(2):353-60. PubMed ID: 16216323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual differences in rats' reactivity to novelty and the unconditioned and conditioned locomotor effects of methamphetamine.
    Bevins RA; Peterson JL
    Pharmacol Biochem Behav; 2004 Sep; 79(1):65-74. PubMed ID: 15388285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Explaining racial and ethnic differences in children's use of stimulant medications.
    Hudson JL; Miller GE; Kirby JB
    Med Care; 2007 Nov; 45(11):1068-75. PubMed ID: 18049347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological studies of the aqueous extract of Sapindus trifoliatus on central nervous system: possible antimigraine mechanisms.
    Arulmozhi DK; Veeranjaneyulu A; Bodhankar SL; Arora SK
    J Ethnopharmacol; 2005 Mar; 97(3):491-6. PubMed ID: 15740885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicological and pharmacological effects of D-arginine.
    Navarro E; Alonso SJ; Martín FA; Castellano MA
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):149-54. PubMed ID: 16128908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference of ethanol and methylmercury in the developing central nervous system.
    Maia CS; Lucena GM; Corrêa PB; Serra RB; Matos RW; Menezes FC; Santos SN; Sousa JB; Costa ET; Ferreira VM
    Neurotoxicology; 2009 Jan; 30(1):23-30. PubMed ID: 19100288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Further research on decalcifying and convulsant drugs].
    TADDEI I
    Boll Soc Ital Biol Sper; 1953 Jul; 29(7):1431-2. PubMed ID: 13140554
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hallucinogenic drugs].
    SLAVIERO E
    Boll Chim Farm; 1957 Apr; 96(4):163-5. PubMed ID: 13436593
    [No Abstract]   [Full Text] [Related]  

  • 36. Are there any psychotherapeutic or psychotomimetic drugs?
    JARVIK M
    Prog Neurobiol (1956); 1958; Vol. 3():203-21; discussion 221-4. PubMed ID: 13579020
    [No Abstract]   [Full Text] [Related]  

  • 37. Environmental causes of central nervous system maldevelopment.
    Rodier PM
    Pediatrics; 2004 Apr; 113(4 Suppl):1076-83. PubMed ID: 15060202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of drugs to reaction components in subjective responses.
    BEECHER HK
    Prog Neurobiol (1956); 1958; Vol. 3():316-23; discussion 323-53. PubMed ID: 13579025
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychotropic drugs in therapy, with special reference to the so-called tranquilizers].
    MESSINI M
    Clin Ter; 1959 Apr; 16(4):321-60. PubMed ID: 13671727
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of ambient temperature on thermal responses to drugs.
    SHEMANO I; NICKERSON M
    Can J Biochem Physiol; 1958 Dec; 36(12):1243-9. PubMed ID: 13596900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.